If you want to develop a thriving business, America is your best bet in 2018.
Read next
Health
GLP-1 Supply Constraints Drive Strategic Pharmaceutical M&A
Global demand for metabolic drugs prompts major drugmakers to acquire specialized contract development and manufacturing organizations.
Health
GLP-1 Therapeutics Reshape Pharmaceutical R&D and Healthcare Costs
Clinical efficacy of GLP-1 receptor agonists prompts widespread reallocation of pharmaceutical research budgets toward metabolic health.
Health
GLP-1 Supply Expansion Targets Global Pharmaceutical Logistics Networks
Pharmaceutical giants invest heavily in contract development and manufacturing organizations to meet metabolic drug demand.
Health
GLP-1 Class Medications Restructure Healthcare Supply Chain Procurement
Widespread adoption of metabolic therapies is altering pharmaceutical distribution channels and impacting medical device manufacturing forecasts.
Health
What Remote Work Did to Mental Health, Honestly
The evidence points in both directions, and which direction applies depends on circumstances the studies rarely capture.
Health
CRISPR-Based Therapeutics Move into Phase III Commercial Pipelines
Clinical trial progressions demonstrate viable delivery mechanisms for gene editing treatments targeting monogenic disorders.